Guiyang Xintian Pharmaceutical Co.,Ltd. (SHE:002873)

SHE:002873 Revenue

Guiyang Xintian Pharmaceutical had revenue of 178.61M CNY in the quarter ending March 31, 2026, a decrease of -7.53%. This brings the company's revenue in the last twelve months to 735.18M, down -15.82% year-over-year. In the year 2025, Guiyang Xintian Pharmaceutical had annual revenue of 749.72M, down -12.57%.

• Revenue (ttm): 735.18M
• Revenue Growth: -15.82%
• P/S Ratio: 3.17
• Revenue / Employee: 529.67K
• Employees: 1,388
• Market Cap: 2.33B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	749.72M	-107.83M	-12.57%
Dec 31, 2024	857.55M	-96.43M	-10.11%
Dec 31, 2023	953.98M	-133.69M	-12.29%
Jan 1, 2023	1.09B	117.83M	12.15%
Jan 1, 2022	969.84M	218.90M	29.15%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 11, 2026

Data Sources Report a data error